AU2010335656B2 - Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue - Google Patents

Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue Download PDF

Info

Publication number
AU2010335656B2
AU2010335656B2 AU2010335656A AU2010335656A AU2010335656B2 AU 2010335656 B2 AU2010335656 B2 AU 2010335656B2 AU 2010335656 A AU2010335656 A AU 2010335656A AU 2010335656 A AU2010335656 A AU 2010335656A AU 2010335656 B2 AU2010335656 B2 AU 2010335656B2
Authority
AU
Australia
Prior art keywords
composition according
composition
solvent
calcipotriol
polyoxypropylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010335656A
Other languages
English (en)
Other versions
AU2010335656A1 (en
Inventor
Karsten Petersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of AU2010335656A1 publication Critical patent/AU2010335656A1/en
Application granted granted Critical
Publication of AU2010335656B2 publication Critical patent/AU2010335656B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010335656A 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue Ceased AU2010335656B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPCT/DK2009/000264 2009-12-22
DK2009000264 2009-12-22
US29310810P 2010-01-07 2010-01-07
US61/293,108 2010-01-07
PCT/DK2010/000184 WO2011076209A2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Publications (2)

Publication Number Publication Date
AU2010335656A1 AU2010335656A1 (en) 2012-07-19
AU2010335656B2 true AU2010335656B2 (en) 2015-05-07

Family

ID=43618136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010335656A Ceased AU2010335656B2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue

Country Status (14)

Country Link
US (1) US20130023501A1 (enExample)
EP (1) EP2515866B1 (enExample)
JP (1) JP5732471B2 (enExample)
CN (1) CN102770121B (enExample)
AU (1) AU2010335656B2 (enExample)
BR (1) BR112012015437A2 (enExample)
CA (1) CA2785254A1 (enExample)
ES (1) ES2452872T3 (enExample)
IL (1) IL220517A (enExample)
MX (1) MX2012007225A (enExample)
NZ (1) NZ601001A (enExample)
RU (1) RU2559084C2 (enExample)
WO (1) WO2011076209A2 (enExample)
ZA (1) ZA201204622B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188686A (zh) * 2013-02-27 2015-12-23 劳瑞·罗伯特·巴特 透皮制剂
KR102486797B1 (ko) * 2016-03-09 2023-01-11 삼성전자 주식회사 전자 장치 및 전자 장치의 디스플레이 구동 방법
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
JP7818752B2 (ja) * 2019-10-25 2026-02-24 カーディオル セラピューティクス インコーポレイテッド 心臓病態の治療に使用するためのカンナビジオール組成物
CN116600786A (zh) 2020-07-28 2023-08-15 阿尔库缇斯生物疗法股份有限公司 含有jak抑制剂和月桂醇聚醚-4的局部制剂
JP2024544404A (ja) 2021-12-15 2024-11-29 アーキュティス・バイオセラピューティクス・インコーポレーテッド Ｓｈｒ０３０２の安定な製剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064450A1 (en) * 1999-04-23 2000-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition
WO2006134272A1 (fr) * 2005-06-17 2006-12-21 Galderma Research & Development Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2008065316A2 (fr) * 2006-11-30 2008-06-05 Galderma S.A. Compositions sous forme d'onguent comprenant un derive de vitamine d

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
MXPA04005260A (es) * 2001-12-03 2005-03-23 Novacea Inc Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
US7977387B2 (en) 2003-07-24 2011-07-12 Leo Pharma A/S Aminobenzophenone compounds
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
CN101115728B (zh) 2004-12-13 2012-12-19 利奥制药有限公司 三唑取代的氨基二苯甲酮化合物
AU2007336538B2 (en) 2006-12-22 2012-04-05 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
KR101571654B1 (ko) 2007-02-28 2015-11-25 레오 파마 에이/에스 신규한 포스포디에스테라제 억제제
US7909624B2 (en) 2007-03-26 2011-03-22 Belkin International, Inc. Carabiner universal serial bus hub
CA2688670A1 (en) 2007-04-19 2008-10-30 Leo Pharma A/S Src family kinase inhibitors
ES2401205T3 (es) * 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
JP2010526824A (ja) 2007-05-11 2010-08-05 ソネボーン インコーポレイテッド シリコーン類似の特性を有するワセリン
SG172206A1 (en) 2008-12-19 2011-07-28 Leo Pharma As Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064450A1 (en) * 1999-04-23 2000-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition
WO2006134272A1 (fr) * 2005-06-17 2006-12-21 Galderma Research & Development Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2008065316A2 (fr) * 2006-11-30 2008-06-05 Galderma S.A. Compositions sous forme d'onguent comprenant un derive de vitamine d

Also Published As

Publication number Publication date
NZ601001A (en) 2014-07-25
IL220517A (en) 2016-08-31
CA2785254A1 (en) 2011-06-30
CN102770121A (zh) 2012-11-07
WO2011076209A3 (en) 2012-02-23
MX2012007225A (es) 2012-07-30
WO2011076209A2 (en) 2011-06-30
ZA201204622B (en) 2013-09-25
JP5732471B2 (ja) 2015-06-10
EP2515866A2 (en) 2012-10-31
RU2012130411A (ru) 2014-01-27
HK1177696A1 (en) 2013-08-30
CN102770121B (zh) 2014-10-15
US20130023501A1 (en) 2013-01-24
RU2559084C2 (ru) 2015-08-10
JP2013515020A (ja) 2013-05-02
AU2010335656A1 (en) 2012-07-19
IL220517A0 (en) 2012-08-30
ES2452872T3 (es) 2014-04-03
EP2515866B1 (en) 2014-02-19
BR112012015437A2 (pt) 2016-03-15

Similar Documents

Publication Publication Date Title
EP2515866B1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
AU2010335654B2 (en) Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
AU2009357263B2 (en) Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
CN101541304B (zh) 含有维生素d的衍生物的呈软膏形式的组合物
AU2010335655B2 (en) Calcipotriol monohydrate nanocrystals
US9254296B2 (en) Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
HK1177696B (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
HK1177695B (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired